HQDrugs.com Internet Drugstore HQDrugs.com Internet Drugstore
HQDrugs.com Internet Drugstore
Our customers' Feedback
Search:
HQ Drugs Perform search
Full drugs list

Generic Sumatriptan - Imitrex

HqDrugs News
www.HQDrugs.com Internet Drugstore
Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Imitrex
Generic Imitrex is used for the treatment of migraine headaches with or without aura (eg, flashing lights, wavy lines, dark spots).
$3.00

High Quality Drugs HQDrugs
Choose your language:
Français  / EURDeutch / EUREspañol / EURItaliano / EURPortuguês / EURPortuguês / USD
High Quality Drugs HQDrugs

Share and Save:
Bookmark and Share

Toll FREE US Canada:
+1 800 532 4808

International:
+1 718 313 1498
+44 200 222 7084


High Quality Drugs HQDrugs
Money backguarantee
High Quality Drugs HQDrugs
Secureshopping
High Quality Drugs HQDrugs.com

MySecureBilling.com certified by:

Secure shopping certificates

Special Offer!

  • OptiNose to begin Phase III trials with intranasal technology - Pharmaceutical Business Review

    OptiNose to begin Phase III trials with intranasal technologyPharmaceutical Business ReviewOptiNose, a drug delivery company, has filed an investigational new drug (IND) with the FDA to use sumatriptan delivered with its novel drug delivery technology, in December 2011.

  • NuPathe to Present at Upcoming Investor Conferences - MarketWatch (press release)

    NuPathe to Present at Upcoming Investor ConferencesMarketWatch (press release)NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine.

  • NuPathe to Present at Upcoming Investor Conferences - Marketwire (press release)

    NuPathe to Present at Upcoming Investor ConferencesMarketwire (press release)NuPathe's lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine.

  • OptiNose testing nose-to-brain delivery tech with migraine drug - FierceDrugDelivery

    OptiNose testing nose-to-brain delivery tech with migraine drugFierceDrugDeliveryOptiNose is launching a Phase III trial to test the migraine drug sumatriptan with its intranasal nose-to-brain drug delivery technology.

  • NuPathe Announces Allowance of Additional U.S. Patent Application for Its ... - MarketWatch (press release)

    NuPathe Announces Allowance of Additional U.

high quality drugs hqdrugs hqdrugs.com
    Copyright 2010. HQDRUGS Ltd. 33 Drugs Pharmacy Network